Zenas Biopharma Inc’s filing revealed that its Director Nunn Jason Raleigh acquired Company’s shares for reported $1.2 million on Oct 09 ’25. In the deal valued at $19.00 per share,63,158 shares were bought. As a result of this transaction, Nunn Jason Raleigh now holds 1,173,395 shares worth roughly $19.49 million.
Then, SR ONE CAPITAL MANAGEMENT, LLC bought 126,315 shares, generating $2,399,985 in total proceeds. Upon buying the shares at $19.00, the 10% Owner now owns 1,917,895 shares.
Before that, ENRIGHT PATRICK G bought 105,265 shares. Zenas Biopharma Inc shares valued at $2,000,035 were divested by the Director at a price of $19.00 per share. As a result of the transaction, ENRIGHT PATRICK G now holds 1,832,669 shares, worth roughly $30.44 million.
Morgan Stanley downgraded its Zenas Biopharma Inc [ZBIO] rating to an Equal-weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in mid March with a ‘”an Outperform”‘ rating. Wolfe Research began covering ZBIO with “an Outperform” recommendation on February 04, 2025. H.C. Wainwright started covering the stock on December 16, 2024. It rated ZBIO as “a Buy”.
Price Performance Review of ZBIO
On Monday, Zenas Biopharma Inc [NASDAQ:ZBIO] saw its stock fall -51.86% to $16.61. Over the last five days, the stock has lost -60.91%. Zenas Biopharma Inc shares have risen nearly 102.81% since the year began. Nevertheless, the stocks have fallen -54.26% over the past one year. While a 52-week high of $44.60 was reached on 01/02/26, a 52-week low of $5.83 was recorded on 01/05/26.
Levels Of Support And Resistance For ZBIO Stock
The 24-hour chart illustrates a support level at 14.24, which if violated will result in even more drops to 11.87. On the upside, there is a resistance level at 18.24. A further resistance level may holdings at 19.87.
How much short interest is there in Zenas Biopharma Inc?
A steep rise in short interest was recorded in Zenas Biopharma Inc stocks on 2025-12-15, growing by 0.34 million shares to a total of 4.95 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 4.61 million shares. There was a rise of 6.93%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 05, 2024 when Rodman & Renshaw began covering the stock and recommended ‘”a Buy”‘ rating along with a $34 price target.
